These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 10655528)

  • 21. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes.
    Couper JJ; Harrison LC; Aldis JJ; Colman PG; Honeyman MC; Ferrante A
    Hum Immunol; 1998 Aug; 59(8):493-9. PubMed ID: 9712353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of age on clinical and immunological characteristics of newly diagnosed type 1 diabetic patients.
    Fajardo C; Piñón F; Carmona E; Sánchez-Cuenca JM; Merino JF; Carlés C
    Acta Diabetol; 2001; 38(1):31-6. PubMed ID: 11487174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y; Qian L; Liu Q; Zou J; Zhou Y; Yang T; Huang G; Zhou Z; Liu Y
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
    Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
    J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response to islet antigens in anti-CD4/prednisolone immune intervention of type 1 diabetes.
    Kohnert KD; Hehmke B; Keilacker H; Ziegler M; Emmrich F; Laube F; Michaelis D
    Int J Clin Lab Res; 1996; 26(1):55-9. PubMed ID: 8739857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1*0501-DQB1*0301 haplotype in Type 1 diabetes mellitus. Belgian Diabetes Registry.
    De Block CE; De Leeuw IH; Rooman RP; Winnock F; Du Caju MV; Van Gaal LF
    Diabet Med; 2000 Aug; 17(8):618-22. PubMed ID: 11073185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T; Nakanishi K; Murase T; Kosaka K
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity.
    Moriguchi M; Noso S; Kawabata Y; Yamauchi T; Harada T; Komaki K; Babaya N; Hiromine Y; Ito H; Yamagata S; Murata K; Higashimoto T; Park C; Yamamoto A; Ohno Y; Ikegami H
    Metabolism; 2011 Jun; 60(6):761-6. PubMed ID: 20825955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR; Genovese S; Cassidy D; Bosi E; Brown TJ; Lai M; Bonifacio E; Bottazzo GF
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and autoantibody pattern in newly diagnosed adult-onset autoimmune diabetes.
    Paschke A; Grzelka A; Zawada A; Zozulińska-Ziółkiewicz D
    Pol Arch Med Wewn; 2013; 123(7-8):401-8. PubMed ID: 23792409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic autoimmune markers in children and adolescents with type 2 diabetes.
    Hathout EH; Thomas W; El-Shahawy M; Nahab F; Mace JW
    Pediatrics; 2001 Jun; 107(6):E102. PubMed ID: 11389300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase.
    Takino H; Kawasaki E; Yano M; Matsumoto K; Uotani S; Okuno S; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
    J Autoimmun; 1994 Jun; 7(3):389-98. PubMed ID: 7916910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes.
    Sabbah E; Savola K; Ebeling T; Kulmala P; Vähäsalo P; Ilonen J; Salmela PI; Knip M
    Diabetes Care; 2000 Sep; 23(9):1326-32. PubMed ID: 10977027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.
    Verge CF; Howard NJ; Rowley MJ; Mackay IR; Zimmet PZ; Egan M; Hulinska H; Hulinsky I; Silvestrini RA; Kamath S
    Diabetologia; 1994 Nov; 37(11):1113-20. PubMed ID: 7867883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.